Appili Therapeutics Inc.
Records under this name other than the patents Appili Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 2 of 2 · Back to Appili Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,700,623 | Arylamidine derivative, salt thereof, and antifungal containing these Term ended Term ended Aug 20, 2026 · USPTO record | Term ended | Term ended Aug 20, 2026 | USPTO record |
| US 7,291,617 | Arylamidine derivative or salt thereof Term ended Term ended Feb 25, 2024 · USPTO record | Term ended | Term ended Feb 25, 2024 | USPTO record |